FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135984787> ?p ?o ?g. }

• W2135984787 endingPage "e371" @default.
• W2135984787 startingPage "e364" @default.
• W2135984787 abstract "Purpose A nationwide retrospective cohort study was conducted by the Japanese Society of Oral and Maxillofacial Surgeons to assess the occurrence of bisphosphonate (BP)-related osteonecrosis of the jaws (BRONJ) during 2006 to 2008 and to elucidate the outcome and factors associated with remission of BRONJ. Materials and Methods A written questionnaire, including the clinical characteristics, management, and outcome of patients with BRONJ, was sent to 248 institutions certified as training facilities by the Japanese Society of Oral and Maxillofacial Surgeons in 2008. Results A total of 568 patients with BRONJ, including suspicious cases, were registered. Of these 568 patients, 263, including the maxilla in 81, the mandible in 160, and both in 22, met the working definition of BRONJ proposed by the American Association of Oral and Maxillofacial Surgeons. The patients included 219 women (83.3%) and 44 men (16.7%). Of these patients, 152 (57.8%) had received intravenous BPs, 104 (39.5%) had received oral BPs, and 7 (2.7%) had received both. The mean duration of administration until onset of BRONJ was 23.6 months for intravenous BPs and 33.2 months for oral BPs. BRONJ was stage 1 in 42 patients (16.0%), stage 2 in 187 (71.1%), stage 3 in 32 (12.2%), and unknown in 2. Of these patients, 34.2% had remission of BRONJ, 46.0% had persistent or progressive disease, and 19.7% died of malignancy or were lost to follow-up. Statistical analysis revealed that surgical treatment, including tooth extraction, sequestrectomy, and segmental mandibulectomy, contributed to the remission of BRONJ. In contrast, conservative treatment, concurrent anticancer drugs, poor oral hygiene, and the use of intravenous BPs did not. Conclusions The relative ratio of BRONJ related to the use of oral BPs was greater in Japan than in the United States and European Union. Surgical treatment contributed to remission of BRONJ, and conservative treatment, concurrent anticancer drugs, poor oral hygiene, and intravenous BPs did not. A nationwide retrospective cohort study was conducted by the Japanese Society of Oral and Maxillofacial Surgeons to assess the occurrence of bisphosphonate (BP)-related osteonecrosis of the jaws (BRONJ) during 2006 to 2008 and to elucidate the outcome and factors associated with remission of BRONJ. A written questionnaire, including the clinical characteristics, management, and outcome of patients with BRONJ, was sent to 248 institutions certified as training facilities by the Japanese Society of Oral and Maxillofacial Surgeons in 2008. A total of 568 patients with BRONJ, including suspicious cases, were registered. Of these 568 patients, 263, including the maxilla in 81, the mandible in 160, and both in 22, met the working definition of BRONJ proposed by the American Association of Oral and Maxillofacial Surgeons. The patients included 219 women (83.3%) and 44 men (16.7%). Of these patients, 152 (57.8%) had received intravenous BPs, 104 (39.5%) had received oral BPs, and 7 (2.7%) had received both. The mean duration of administration until onset of BRONJ was 23.6 months for intravenous BPs and 33.2 months for oral BPs. BRONJ was stage 1 in 42 patients (16.0%), stage 2 in 187 (71.1%), stage 3 in 32 (12.2%), and unknown in 2. Of these patients, 34.2% had remission of BRONJ, 46.0% had persistent or progressive disease, and 19.7% died of malignancy or were lost to follow-up. Statistical analysis revealed that surgical treatment, including tooth extraction, sequestrectomy, and segmental mandibulectomy, contributed to the remission of BRONJ. In contrast, conservative treatment, concurrent anticancer drugs, poor oral hygiene, and the use of intravenous BPs did not. The relative ratio of BRONJ related to the use of oral BPs was greater in Japan than in the United States and European Union. Surgical treatment contributed to remission of BRONJ, and conservative treatment, concurrent anticancer drugs, poor oral hygiene, and intravenous BPs did not." @default.
• W2135984787 created "2016-06-24" @default.
• W2135984787 creator A5012443552 @default.
• W2135984787 creator A5012502039 @default.
• W2135984787 creator A5014517165 @default.
• W2135984787 creator A5024134718 @default.
• W2135984787 creator A5029014038 @default.
• W2135984787 creator A5043255277 @default.
• W2135984787 creator A5044432222 @default.
• W2135984787 creator A5050515361 @default.
• W2135984787 creator A5076374528 @default.
• W2135984787 creator A5080733850 @default.
• W2135984787 date "2011-11-01" @default.
• W2135984787 modified "2023-10-16" @default.
• W2135984787 title "Nationwide Survey for Bisphosphonate-Related Osteonecrosis of the Jaws in Japan" @default.
• W2135984787 cites W1974788477 @default.
• W2135984787 cites W2015338398 @default.
• W2135984787 cites W2032829585 @default.
• W2135984787 cites W2050247107 @default.
• W2135984787 cites W2055352964 @default.
• W2135984787 cites W2056380603 @default.
• W2135984787 cites W2065414366 @default.
• W2135984787 cites W2075716878 @default.
• W2135984787 cites W2077554194 @default.
• W2135984787 cites W2084478295 @default.
• W2135984787 cites W2089384713 @default.
• W2135984787 cites W2092364392 @default.
• W2135984787 cites W2096967244 @default.
• W2135984787 cites W2107208293 @default.
• W2135984787 cites W2110711752 @default.
• W2135984787 cites W2118377751 @default.
• W2135984787 cites W2122095067 @default.
• W2135984787 cites W2150904792 @default.
• W2135984787 cites W2163852287 @default.
• W2135984787 cites W2169512870 @default.
• W2135984787 cites W2314421239 @default.
• W2135984787 cites W2324355713 @default.
• W2135984787 cites W2510438684 @default.
• W2135984787 cites W29459619 @default.
• W2135984787 cites W4239901602 @default.
• W2135984787 cites W45400945 @default.
• W2135984787 doi "https://doi.org/10.1016/j.joms.2011.03.051" @default.
• W2135984787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21782307" @default.
• W2135984787 hasPublicationYear "2011" @default.
• W2135984787 type Work @default.
• W2135984787 sameAs 2135984787 @default.
• W2135984787 citedByCount "96" @default.
• W2135984787 countsByYear W21359847872012 @default.
• W2135984787 countsByYear W21359847872013 @default.
• W2135984787 countsByYear W21359847872014 @default.
• W2135984787 countsByYear W21359847872015 @default.
• W2135984787 countsByYear W21359847872016 @default.
• W2135984787 countsByYear W21359847872017 @default.
• W2135984787 countsByYear W21359847872018 @default.
• W2135984787 countsByYear W21359847872019 @default.
• W2135984787 countsByYear W21359847872020 @default.
• W2135984787 countsByYear W21359847872021 @default.
• W2135984787 countsByYear W21359847872022 @default.
• W2135984787 countsByYear W21359847872023 @default.
• W2135984787 crossrefType "journal-article" @default.
• W2135984787 hasAuthorship W2135984787A5012443552 @default.
• W2135984787 hasAuthorship W2135984787A5012502039 @default.
• W2135984787 hasAuthorship W2135984787A5014517165 @default.
• W2135984787 hasAuthorship W2135984787A5024134718 @default.
• W2135984787 hasAuthorship W2135984787A5029014038 @default.
• W2135984787 hasAuthorship W2135984787A5043255277 @default.
• W2135984787 hasAuthorship W2135984787A5044432222 @default.
• W2135984787 hasAuthorship W2135984787A5050515361 @default.
• W2135984787 hasAuthorship W2135984787A5076374528 @default.
• W2135984787 hasAuthorship W2135984787A5080733850 @default.
• W2135984787 hasConcept C122246415 @default.
• W2135984787 hasConcept C126322002 @default.
• W2135984787 hasConcept C141071460 @default.
• W2135984787 hasConcept C146357865 @default.
• W2135984787 hasConcept C151730666 @default.
• W2135984787 hasConcept C167135981 @default.
• W2135984787 hasConcept C199343813 @default.
• W2135984787 hasConcept C2776541429 @default.
• W2135984787 hasConcept C2777251235 @default.
• W2135984787 hasConcept C2777556957 @default.
• W2135984787 hasConcept C2779360543 @default.
• W2135984787 hasConcept C2779399171 @default.
• W2135984787 hasConcept C71924100 @default.
• W2135984787 hasConcept C72563966 @default.
• W2135984787 hasConcept C86803240 @default.
• W2135984787 hasConceptScore W2135984787C122246415 @default.
• W2135984787 hasConceptScore W2135984787C126322002 @default.
• W2135984787 hasConceptScore W2135984787C141071460 @default.
• W2135984787 hasConceptScore W2135984787C146357865 @default.
• W2135984787 hasConceptScore W2135984787C151730666 @default.
• W2135984787 hasConceptScore W2135984787C167135981 @default.
• W2135984787 hasConceptScore W2135984787C199343813 @default.
• W2135984787 hasConceptScore W2135984787C2776541429 @default.
• W2135984787 hasConceptScore W2135984787C2777251235 @default.
• W2135984787 hasConceptScore W2135984787C2777556957 @default.
• W2135984787 hasConceptScore W2135984787C2779360543 @default.
• W2135984787 hasConceptScore W2135984787C2779399171 @default.
• W2135984787 hasConceptScore W2135984787C71924100 @default.

• next